Therapeutic Proteins and Peptides

Erscheinungsjahr 2018
ISBN: 978-0-12-814340-7
Verlag: William Andrew Publishing

Buch, Englisch, 408 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 840 g

Therapeutic Proteins and Peptides, Volume 112 in an ongoing series promotes further research in the discovery of new therapeutic targets that can be affected by therapeutic proteins and peptides to cure or manage symptoms of human diseases, with this release focusing on the Rational Design of Stable Liquid Formulations of Biopharmaceuticals, Formulation strategies for peptides, proteins and antibodies using nanotechnology, the Solution structural dynamics of therapeutic peptides and their adsorption on plasmonic nanoparticles, Enzymatic approaches of protein-polymer conjugation, Chimeric small antibody fragments as a strategy to deliver therapeutic payloads, Smart cell-penetrating peptide-based techniques for cytoplasmic delivery of therapeutic macromolecules, and more.

Zielgruppe

<p>Pharmacologists, protein chemists, formulation specialists, medical doctors, cell biologists, immunologists, structural biologists, computational biochemists and other researchers working in this field. Articles published here would also be of a great benefit to medical, biology and pharmacology students specializing in this field.</p>

Autoren/Hrsg.

Weitere Mitwirkende

Donev, Rossen

Fachgebiete

• Naturwissenschaften Biowissenschaften Molekularbiologie
• Naturwissenschaften Biowissenschaften Zellbiologie
• Naturwissenschaften Biowissenschaften Biochemie (nichtmedizinisch)

Inhaltsverzeichnis

1. Rational Design of Liquid Formulations of Proteins Mark C. Manning, Jun Liu, Tiansheng Li and Ryan E. Holcomb 2. Therapeutic Monoclonal Antibodies Delivery for the Glioblastoma Treatment Flávia Sousa, Rui P. Moura, Elias Moreira, Cláudia Martins and Bruno Sarmento 3. Dynamical Behavior of Somatostatin-14 and Its Cyclic Analogues as Analyzed in Bulk and on Plasmonic Silver Nanoparticles Belén Hernández, Yves-Marie Coïc, Eduardo López-Tobar, Santiago Sanchez-Cortes, Bruno Baron, Fernando Pflüger, Sergei G. Kruglik, Régis Cohen and Mahmoud Ghomi 4. Transglutaminase and Sialyltransferase Enzymatic Approaches for Polymer Conjugation to Proteins Katia Maso, Antonella Grigoletto and Gianfranco Pasut 5. Chimeric Small Antibody Fragments as Strategy to Deliver Therapeutic Payloads Sandra Aguiar, Joana Dias, Ana M. Manuel, Roberto Russo, Pedro M. P. Gois, Frederico A. da Silva and Joao Goncalves 6. Smart Cell-Penetrating Peptide-Based Techniques for Intracellular Delivery of Therapeutic Macromolecules Yang He, Feng Li and Yongzhuo Huang 7. In Silico Tools and Databases for Designing Peptide-Based Vaccine and Drugs Salman S. Usmani, Rajesh Kumar, Sherry Bhalla, Vinod Kumar and Gajendra P.S. Raghava 8. Protein and Peptides for Elderly Health Nan Shang, Chalamaiah Meram, Nandika Bandara and Jianping Wu 9. Peptide Derivates of Erythropoietin in the Treatment of Neuroinflammation and Neurodegeneration Ilkcan Ercan, Kemal U. Tufekci, Ezgi Karaca, Sermin Genc and Kursad Genc 10. The Structure/Function Relationship in Antimicrobial Peptides: What Can we Obtain From Structural Data? Marlon H. Cardoso, Karen G. N. Oshiro, Samilla B. Rezende, Elizabete S. Cândido and Octávio L. Franco 11. Linear Analogues of Lipopeptide Battacin With Potent In Vitro Activity Against S. aureus Hugh D. Glossop, Esperanza Pearl, Gayan H. De Zoysa and Vijayalekshmi Sarojini

Über Autor(innen)

Donev, Rossen
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.